Literature DB >> 11174985

Echocardiographic Guidance for Endomyocardial Biopsy.

John H. Drury1, Arthur J. Labovitz, Leslie W. Miller.   

Abstract

Endomyocardial biopsy is fundamental to the success of cardiac transplantation and can also provide important information for the diagnosis of primary and secondary myocardial pathology. Classically, endomyocardial biopsy procedures have utilized fluoroscopy to guide bioptome manipulation. However, echocardiographic guidance has many distinct advantages. We review our experience of 4301 echocardiography guided endomyocardial biopsy procedures. Our overall major complication rate was 0.4% with one right ventricular perforation and no procedure related mortality. These results compare favorably to traditional fluoroscopic techniques. Echocardiographic guidance for endomyocardial biopsy is safe, effective, and efficient.

Year:  1997        PMID: 11174985     DOI: 10.1111/j.1540-8175.1997.tb00754.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  4 in total

Review 1.  An approach to endomyocardial biopsy interpretation.

Authors:  K S Cunningham; J P Veinot; J Butany
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy.

Authors:  Juyup Han; Yongwhi Park; Hyunsang Lee; Hyunjae Kang; Hyungseop Kim; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 3.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

4.  Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.

Authors:  Ludwig T Weckbach; Ulrich Maurer; Rene Schramm; Bruno C Huber; Korbinian Lackermair; Max Weiss; Bruno Meiser; Christian Hagl; Steffen Massberg; Sandra Eifert; Ulrich Grabmaier
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.